Results 41 to 50 of about 6,278 (218)

Impact of gut hormone FGF-19 on type-2 diabetes and mitochondrial recovery in a prospective study of obese diabetic women undergoing bariatric surgery [PDF]

open access: yes, 2017
Background: The ileal-derived hormone, fibroblast growth factor 19 (FGF-19), may promote weight loss and facilitate type-2 diabetes mellitus remission in bariatric surgical patients.
Fried, M.   +19 more
core   +1 more source

Long-Term Risks of Benign and Malign Complications after Endoscopic Sphincterotomy in the Management of Benign Biliopancreatic Pathology: A Cohort Study

open access: yesEurasian Journal of Medicine
Background: Endoscopic retrograde cholangiopancreatography (ERCP) is the preferred technique for treating pathologies of the bile duct. It has been suggested that this procedure, combined with sphincterotomy, may influence the subsequent development of ...
Mercedes Ibáñez   +5 more
doaj   +1 more source

Correction of metabolic syndrome and liver disease after biliopancreatic diversion in morbidly obese patients

open access: yesОжирение и метаболизм, 2012
The aim of this study was to analyze the corrections of the metabolic syndrome and the liver dysfunction of morbidly obese patients after the biliapancreatic diversion (BPD).

doaj   +1 more source

IGFBP-2 partly mediates the early metabolic improvements caused by bariatric surgery

open access: yesCell Reports Medicine, 2021
Summary: Insulin-like growth factor-binding protein (IGFBP)-2 is a circulating biomarker of cardiometabolic health. Here, we report that circulating IGFBP-2 concentrations robustly increase after different bariatric procedures in humans, reaching higher ...
Justine Faramia   +22 more
doaj   +1 more source

Bariatric Surgery Prior to Hip and Knee Arthroplasty: A Systematic Review and Meta‐Analysis of Postoperative Outcomes

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Obesity is a major risk factor for perioperative complications following total joint arthroplasty (TJA). Bariatric surgery has been proposed to reduce these risks, but previous studies report inconsistent findings. The effect of bariatric surgery before arthroplasty remains uncertain.
Mohammad Faraz   +3 more
wiley   +1 more source

Biliopancreatic diversion with duodenojejunal exclusion associated with truncal vagotomy: a new proposal for type 2 diabetes mellitus treatment Derivação biliopancreática com exclusão duodeno-jejunal associada à vagotomia troncular: uma nova proposta para o tratamento do diabetes melito tipo 2

open access: yesActa Cirúrgica Brasileira, 2012
PURPOSE: To evaluate the effectiveness of the biliopancreatic diversion surgery with duodenojejunal exclusion in combination with truncal vagotomy in type 2 diabetes mellitus (T2DM) patients with overweight or class I or II obesity.
Edson Alleotti   +6 more
doaj   +1 more source

Effects of Weight Loss Interventions on Gut Microbiota‐Derived Metabolites Linked to Cardiometabolic Health: A Systematic Review and Meta‐Analysis

open access: yesObesity Reviews, EarlyView.
ABSTRACT Background Gut microbiota‐derived metabolites are emerging as potential mediators between obesity and cardiometabolic conditions. While weight loss interventions modify microbiota composition, their effects on systemic microbial metabolites remain unclear.
Fernando Q. Iorra   +5 more
wiley   +1 more source

Endoscopic Management of Weight Recurrence Following Bariatric Surgery

open access: yesFrontiers in Endocrinology, 2022
Metabolic and bariatric surgery is the most effective therapy for weight loss and improving obesity-related comorbidities, comprising the Roux-en-Y gastric bypass (RYGB), gastric banding, sleeve gastrectomy (SG), and biliopancreatic diversion with ...
Donna Maria Abboud   +5 more
doaj   +1 more source

Is AMP‐activated protein kinase activation a central mechanism of cardio‐metabolic outcomes after metabolic and bariatric surgery?

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3480-3490, May 2026.
Abstract Metabolic and bariatric surgery (MBS) is the most effective treatment for severe obesity. It usually results in spectacular weight loss, associated with improvements of obesity‐associated comorbidities. The mechanisms underlying these benefits are not fully understood but could involve a postoperative activation of the enzyme 5′ AMP‐activated ...
Adrien Delcour, Nathalie Niederhoffer
wiley   +1 more source

Glucose metabolism and incretins level in morbidly obese patients and in patients after biliopancreatic diversion performed for morbid obesity

open access: yesОжирение и метаболизм, 2014
We’ve studied a carbohydrate metabolism in morbidly obese (MO) patients and the patients after bariatric surgery. The patients of the 1st group had BMI>40 (n=22) and no history of diabetes mellitus.

doaj   +1 more source

Home - About - Disclaimer - Privacy